102 related articles for article (PubMed ID: 1411390)
21. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].
Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M
Therapie; 1999; 54(1):41-8. PubMed ID: 10216421
[TBL] [Abstract][Full Text] [Related]
22. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
Ewe K; Becker K; Ueberschaer B
Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
[TBL] [Abstract][Full Text] [Related]
23. Mesalamine for ulcerative colitis.
Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508
[No Abstract] [Full Text] [Related]
24. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
[TBL] [Abstract][Full Text] [Related]
25. [Mesalazine (5-ASA) in ulcerative colitis].
Dybdahl JH
Tidsskr Nor Laegeforen; 1990 Oct; 110(24):3130-1. PubMed ID: 2237871
[No Abstract] [Full Text] [Related]
26. Cryptogenic fibrosing alveolitis predating ulcerative colitis.
Pérez de Llano LA; Lancho A; Soilán del Cerro JL; López-Róses L
Am J Gastroenterol; 1996 Apr; 91(4):822-3. PubMed ID: 8677973
[No Abstract] [Full Text] [Related]
27. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
28. Review article: aminosalicylates in inflammatory bowel disease.
Hanauer SB
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
[TBL] [Abstract][Full Text] [Related]
29. Folliculitis and mesalamine.
Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
[No Abstract] [Full Text] [Related]
30. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity.
Bresci G; Carrai M; Venturini G; Gambardella L
Int J Tissue React; 1990; 12(4):243-6. PubMed ID: 1980911
[TBL] [Abstract][Full Text] [Related]
31. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
[TBL] [Abstract][Full Text] [Related]
32. [Acute interstitial nephritis caused by 5-aminosalicylic acid?].
Ruf-Ballauf W; Hofstädter F; Krentz K
Internist (Berl); 1989 Apr; 30(4):262-4. PubMed ID: 2661466
[No Abstract] [Full Text] [Related]
33. [5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
Cappello M; Puleo A; Calabrese A; Cipolla C; Orlando A; Gatto G; Oliva L; Cottone M
Recenti Prog Med; 1987 Feb; 78(2):76-8. PubMed ID: 2884701
[No Abstract] [Full Text] [Related]
34. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
Baker DE; Kane S
Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
[TBL] [Abstract][Full Text] [Related]
35. Drug induced otalgia due to mesalazine and sulphasalazine.
Wareing M; Mitchell D
J Laryngol Otol; 1996 May; 110(5):466-7. PubMed ID: 8762319
[TBL] [Abstract][Full Text] [Related]
36. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539
[No Abstract] [Full Text] [Related]
37. Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
Safdi AV; Cohen RD
Aliment Pharmacol Ther; 2007 Nov; 26(9):1179-86. PubMed ID: 17944732
[TBL] [Abstract][Full Text] [Related]
38. [Acute alveolitis in ulcerative colitis: extra-intestinal organ complication or drug side effect].
Hesselmann J; Kuhn M; Ostendorf PC; Huep WW
Leber Magen Darm; 1991 Jan; 21(1):26-8, 31. PubMed ID: 2027303
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
Dölle W; Daiss W
Verh Dtsch Ges Inn Med; 1988; 94():184-91. PubMed ID: 2905099
[No Abstract] [Full Text] [Related]
40. [Differential diagnosis problem of pulmonary changes in ulcerative colitis].
Djurić M; Povazan D; Secen S; Jović J
Vojnosanit Pregl; 2010 Jun; 67(6):511-4. PubMed ID: 20629432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
